SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 95 of 100
International
Sanofi taps Bayer’s Brandicourt for CEO job
By
Geoffrey Smith
February 20, 2015
Features
Candidate to lead FDA has close ties to big pharma
By
TIME
February 19, 2015
Leadership
Big Beef keeps getting bigger, thanks to growth drugs with unclear safety records
By
Deena Shanker
February 13, 2015
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By
Laura Lorenzetti
February 11, 2015
Leadership
Peter Thiel has never met a regulation he didn’t hate
By
Ben Geier
February 11, 2015
Features
Biosimilars may one day save your life. But what are they?
By
Laura Lorenzetti
February 6, 2015
Finance
Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By
Jen Wieczner
February 6, 2015
Finance
Pfizer to acquire Hospira in a deal worth about $15 billion
By
Fortune Editors
February 5, 2015
Features
There’s a national shortage of saline solution. Yeah, we’re talking salt water. Huh?
By
Erika Fry
February 5, 2015
Features
In speed mode, FDA approves Pfizer’s big new drug early
By
Jen Wieczner
February 4, 2015
Finance
FDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
By
Laura Lorenzetti
February 4, 2015
Features
Is it time for the FDA to consider cost when it comes to new drugs?
By
Laura Lorenzetti
February 4, 2015
Tech
Bigger drug discounts put question mark over Gilead’s stellar run
By
Reuters
and
Fortune Editors
February 4, 2015
Finance
How to save on your prescription meds (yep, there’s an app for that)
By
Jean Chatzky
February 3, 2015
Finance
After Allergan loss, is Valeant dumpster diving?
By
Jen Wieczner
January 31, 2015
Most Popular
AI
Meta's 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is 'vibe coding' right now
By
Eva Roytburg
Politics
First Tucker Carlson, now Ted Cruz: Conservatives are talking about an ‘unbelievably dangerous’ precedent being set by...
By
Nino Paoli
Politics
White House scrambles to clear up H-1B visa confusion after panic throws corporate America into chaos overnight
By
Jason Ma